Belgium· BE-AMP-SAM660620-00
Inzolfi 0.25 mg
A fingolimod product containing fingolimod hydrochloride, registered in Belgium by Sandoz. The same ATC class is registered in 3 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Fingolimod is registered in 3 of 19 countries.
Countries holding a registration under ATC L04AA27 (fingolimod), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 2 of them publish a price we can compare per daily dose
Fingolimod · ATC L04AA27
3 / 19 countries
- Belgiumprice
- Ireland
- Polandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Fingolimod Hydrochloride
- Manufacturer
- Sandoz
- Country
- Belgium (BE)
- ATC code
- L04AA27
- ATC class
- Fingolimod
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
584 interactions on record for fingolimod.
Graded by severity as the source publishes them — 503 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fingolimod · interactions on record
584 records
- 503 severe
- 77 moderate
- 4 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Fingolimod in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandFingolimod Devatis 0.25 mg, KapselnDevatis AG
- FinlandFingolimod DevatisDevatis GmbH
- PolandFingolimod TevaTeva Pharmaceuticals Polska Sp. z o.o.
- SpainFINGOLIMOD SWANPOND INVESTMENTS 0,25 MG CAPSULAS DURAS EFGSwan Pond Investments Limited
- SwedenFingolimod Devatis 0,25 mg Kapsel, hårdDevatis GmbH
- CzechiaGILENYANovartis Europharm Limited, Dublin
- NetherlandsFingolimod Devatis 0,25 mg, harde capsulesDevatis GmbH
- FranceFINGOLIMOD TEVA 0,25 mg, géluleTEVA SANTE
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Areleptan, Chantico
- Bulgaria · Chantico, Inzolfi
- Cyprus · Fingolimod Adelco, Fingolimod Remedica
- Czechia · Areleptan, Bonaxon
- Germany · Fingod, Fingolimod 123 Acurae Pharma
- Denmark · Areleptan, Bonaxon
- Estonia · Chantico, Efigalo
- Spain · Fingolimod, Fingolimod Aurovitas
- Finland · Fingolimod, Fingolimod Avansor
- France · Fingolimod Arrow, Fingolimod Benta
- United Kingdom (Northern Ireland) · Fingolimod, Fingolimod Amarox
- Greece · Fingolimod Adelco, Fingolimod Medochemie
- Croatia · Areleptan, Arlesias
- Hungary · Bonaxon, Chantico
- Ireland · Fingolimod Clonmel, Fingolimod Flynn Pharma
- Iceland · Fingolimod, Fingolimod Accord
- Italy · Fingolimod Aurobindo, Fingolimod Dr. Reddy’s
- Liechtenstein · Fingolimod Accord, Fingolimod Mylan
- Lithuania · Chantico, Efigalo
- Luxembourg · Fingolimod Eg, Fingolimod Ratiopharm
- Latvia · Bonaxon, Chantico
- Malta · Fingolimod Denk, Fingolimod Remedica
- Netherlands · Chantico, Fenoxa
- Norway · Areleptan, Fingolimod Accord
- Poland · Bonaxon, Chantico
- Portugal · Bluesar, Fingolimod Bluefish
- Romania · Fingolimod Dr. Reddys, Fingolimod Msn
- Sweden · Areleptan, Fingolimod Amarox
- Slovenia · Areleptan, Arlesias
- Slovakia · Areleptan, Bonaxon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fb668755-eac7-4781-af25-b84fdf15daab GET /v1/drugs/fb668755-eac7-4781-af25-b84fdf15daab?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"source": "afmps",
"status": "REVOKED",
"name_en": "Inzolfi 0.25 mg",
"name_fr": "Inzolfi 0.25 mg",
"name_nl": "Inzolfi 0.25 mg",
"amp_code": "SAM660620-00",
"strengths": [
"0.2800",
"0.2800",
"0.2500",
"0.2500",
"0.6030",
"46.8670"
],
"pack_count": 6,
"substances": [
"Fingolimod Hydrochloride",
"Fingolimod",
"Hydroxypropylbetadex",
"Mannitol"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Fingolimod",
"authorisation_numbers": [
"BE660620"
]
}See everything about fingolimod.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.